ResearcherDalian Medical UniversityActive in the last 2 years
Xiaodong Ma
Matched on ORCID iD 0000-0002-5189-6287; OpenAlex author ID A5101787221. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 5
- Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells" [P… Co-author DOI 10.1016/j.phymed.2024.156301↗
- Design, synthesis and activity evaluation of isopropylsulfonyl-substituted 2,4- diarylaminopyrimidine derivatives as FAK inhibitors for the potential treatment… Co-author DOI 10.1016/j.ejmech.2022.114607↗
- Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells. Co-author DOI 10.1016/j.phymed.2021.153711↗
- Selaginellin B induces apoptosis and autophagy in pancreatic cancer cells via the JAK2/STAT3 signaling pathway. Co-author PMID 33312355↗
- Phosphamide-containing diphenylpyrimidine analogues (PA-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with enhanced activity against pancreatic cance… Last author DOI 10.1016/j.bmc.2017.09.041↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Peng Chu · 3 shared papers, 2020–2025 · strength 0.43
- Paper Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabi… DOI 10.1016/j.phymed.2024.156301↗
- Paper Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant … DOI 10.1016/j.phymed.2021.153711↗
- Paper Selaginellin B induces apoptosis and autophagy in pancreatic cancer cells via the JAK2/STAT3 signaling pathway. PMID 33312355↗
- Jinyong Peng · 3 shared papers, 2020–2025 · strength 0.43
- Paper Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabi… DOI 10.1016/j.phymed.2024.156301↗
- Paper Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant … DOI 10.1016/j.phymed.2021.153711↗
- Paper Selaginellin B induces apoptosis and autophagy in pancreatic cancer cells via the JAK2/STAT3 signaling pathway. PMID 33312355↗
- Abdullah Shopit · 3 shared papers, 2020–2025 · strength 0.43
- Paper Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabi… DOI 10.1016/j.phymed.2024.156301↗
- Paper Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant … DOI 10.1016/j.phymed.2021.153711↗
- Paper Selaginellin B induces apoptosis and autophagy in pancreatic cancer cells via the JAK2/STAT3 signaling pathway. PMID 33312355↗
- Zeyao Tang · 3 shared papers, 2020–2025 · strength 0.43
- Paper Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabi… DOI 10.1016/j.phymed.2024.156301↗
- Paper Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant … DOI 10.1016/j.phymed.2021.153711↗
- Paper Selaginellin B induces apoptosis and autophagy in pancreatic cancer cells via the JAK2/STAT3 signaling pathway. PMID 33312355↗
- Xiaohong H. Shu · 2 shared papers, 2021–2025 · strength 0.32
- Paper Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabi… DOI 10.1016/j.phymed.2024.156301↗
- Paper Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant … DOI 10.1016/j.phymed.2021.153711↗
- Changyuan Wang · 2 shared papers, 2017–2022 · strength 0.22
- Paper Design, synthesis and activity evaluation of isopropylsulfonyl-substituted 2,4- diarylaminopyrimidine derivatives as FA… DOI 10.1016/j.ejmech.2022.114607↗
- Paper Phosphamide-containing diphenylpyrimidine analogues (PA-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with en… DOI 10.1016/j.bmc.2017.09.041↗
- Xu Zheng · 1 shared paper, 2022 · strength 0.15
- Xing Li · 1 shared paper, 2022 · strength 0.15
- Yanxia Li · 1 shared paper, 2022 · strength 0.15
- Zhaolin Sun · 1 shared paper, 2020 · strength 0.10
- Yanxia Li · 1 shared paper, 2017 · strength 0.06
- He Liu · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.